Natural Investments LLC bought a new position in The Procter & Gamble Company (NYSE:PG - Free Report) during the fourth quarter, according to its most recent 13F filing with the SEC. The fund bought 12,652 shares of the company's stock, valued at approximately $2,121,000.
Several other hedge funds have also recently made changes to their positions in PG. Lakeridge Wealth Management LLC increased its position in Procter & Gamble by 0.6% during the fourth quarter. Lakeridge Wealth Management LLC now owns 10,807 shares of the company's stock worth $1,812,000 after buying an additional 60 shares in the last quarter. Colton Groome Financial Advisors LLC boosted its stake in shares of Procter & Gamble by 3.2% during the fourth quarter. Colton Groome Financial Advisors LLC now owns 1,995 shares of the company's stock valued at $334,000 after acquiring an additional 62 shares during the last quarter. Tevis Investment Management increased its position in Procter & Gamble by 0.6% during the 4th quarter. Tevis Investment Management now owns 11,633 shares of the company's stock worth $1,950,000 after purchasing an additional 65 shares in the last quarter. Dakota Community Bank & Trust NA increased its position in Procter & Gamble by 3.3% during the 4th quarter. Dakota Community Bank & Trust NA now owns 2,078 shares of the company's stock worth $348,000 after purchasing an additional 66 shares in the last quarter. Finally, Alhambra Investment Management LLC raised its stake in Procter & Gamble by 1.2% in the 4th quarter. Alhambra Investment Management LLC now owns 5,785 shares of the company's stock valued at $970,000 after purchasing an additional 66 shares during the last quarter. 65.77% of the stock is currently owned by hedge funds and other institutional investors.
Procter & Gamble Trading Down 1.8 %
Shares of Procter & Gamble stock traded down $3.19 during trading hours on Tuesday, hitting $173.07. The company's stock had a trading volume of 11,030,875 shares, compared to its average volume of 6,404,080. The business has a fifty day moving average of $167.14 and a 200 day moving average of $169.84. The Procter & Gamble Company has a 1-year low of $153.52 and a 1-year high of $180.43. The company has a quick ratio of 0.55, a current ratio of 0.76 and a debt-to-equity ratio of 0.50. The company has a market capitalization of $405.83 billion, a PE ratio of 27.56, a P/E/G ratio of 3.76 and a beta of 0.41.
Procter & Gamble (NYSE:PG - Get Free Report) last announced its quarterly earnings results on Wednesday, January 22nd. The company reported $1.88 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.86 by $0.02. Procter & Gamble had a return on equity of 33.00% and a net margin of 18.35%. The firm had revenue of $21.88 billion during the quarter, compared to the consensus estimate of $21.66 billion. During the same period in the prior year, the firm earned $1.84 EPS. The firm's quarterly revenue was up 2.1% compared to the same quarter last year. As a group, equities analysts forecast that The Procter & Gamble Company will post 6.91 EPS for the current year.
Procter & Gamble Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Tuesday, February 18th. Shareholders of record on Friday, January 24th were issued a $1.0065 dividend. This represents a $4.03 dividend on an annualized basis and a yield of 2.33%. The ex-dividend date of this dividend was Friday, January 24th. Procter & Gamble's dividend payout ratio is presently 64.01%.
Analyst Ratings Changes
Several research firms have issued reports on PG. Royal Bank of Canada reaffirmed a "sector perform" rating and set a $164.00 price target on shares of Procter & Gamble in a research note on Thursday, January 23rd. Barclays raised their target price on shares of Procter & Gamble from $155.00 to $159.00 and gave the stock an "equal weight" rating in a research report on Thursday, January 23rd. Piper Sandler cut their price target on Procter & Gamble from $173.00 to $172.00 and set a "neutral" rating for the company in a report on Monday, February 24th. Wells Fargo & Company raised their price objective on Procter & Gamble from $176.00 to $180.00 and gave the stock an "overweight" rating in a report on Thursday, January 23rd. Finally, Stifel Nicolaus upped their target price on Procter & Gamble from $161.00 to $165.00 and gave the company a "hold" rating in a research note on Thursday, January 23rd. Seven investment analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have given a strong buy rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $181.11.
View Our Latest Analysis on PG
Insider Buying and Selling at Procter & Gamble
In other news, CEO Gary A. Coombe sold 18,000 shares of the firm's stock in a transaction dated Tuesday, February 25th. The stock was sold at an average price of $171.66, for a total transaction of $3,089,880.00. Following the completion of the sale, the chief executive officer now directly owns 22,051 shares in the company, valued at $3,785,274.66. This trade represents a 44.94 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Marc S. Pritchard sold 90,450 shares of the business's stock in a transaction dated Thursday, January 23rd. The stock was sold at an average price of $163.84, for a total value of $14,819,328.00. Following the completion of the transaction, the insider now owns 172,814 shares in the company, valued at approximately $28,313,845.76. This trade represents a 34.36 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 143,450 shares of company stock valued at $23,988,008 over the last 90 days. 0.18% of the stock is owned by corporate insiders.
About Procter & Gamble
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Recommended Stories

Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.
Get This Free Report